Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Diabetes insipidus treated by DDAVP

J R Short, A Isles

    The Medical Journal of Australia
    |May 15, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Diabetes insipidus treatment improved with 1-deamino-8-D-arginine-vasopressin (DDAVP) nasal drops, offering a better alternative to painful injections. This new therapy avoids side effects associated with older pitressin forms.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Staphylococcal lung abscess in a child with cystic fibrosis: Case report & review of literature.

    Respiratory medicine case reports·2020
    Same author

    The point-of-referral barrier--a factor in the success of telehealth.

    Journal of telemedicine and telecare·2001
    Same author

    When is a clone not a clone?

    Trends in genetics : TIG·2001
    Same author

    Reversible regulation of mouse genes.

    Trends in genetics : TIG·2001
    Same author

    The management of acute laryngo-tracheo-bronchitis (croup): a consensus view.

    Journal of paediatrics and child health·1992
    Same author

    Short-term nutritional supplementation during management of pulmonary exacerbations in cystic fibrosis: a controlled study, including effects of protein turnover.

    The American journal of clinical nutrition·1988

    Area of Science:

    • Endocrinology
    • Pharmacology

    Background:

    • Diabetes insipidus is effectively managed symptomatically with pitressin.
    • Previous intranasal pitressin formulations caused rhinitis and were ineffective.
    • Pitressin tannate in oil injections, while effective, were painful and led to abscesses.

    Observation:

    • The introduction of 1-deamino-8-D-arginine-vasopressin (DDAVP) offers a novel therapeutic approach.
    • DDAVP can be administered via simple nasal instillation.

    Findings:

    • DDAVP represents a significant advancement in diabetes insipidus treatment.
    • Nasal DDAVP provides an effective and convenient alternative to injections and less effective intranasal pitressin forms.

    Implications:

    Related Experiment Videos

  • DDAVP improves patient compliance and quality of life.
  • This new formulation reduces the risk of injection-related complications.
  • DDAVP is poised to become the preferred treatment for diabetes insipidus.